Citation 6561

NAVARRO,P: GINER,RM: RECIO,MC: MANEZ,S: CERDA NIVOLAS,M: RIOS,JL:. (2001). IN VIVO ANTI-INFLAMMATORY ACTIVITY OF SAPONINS FROM BUPLEURUM ROTUNDIFOLIUM.. 68(10)

Citation Details

Title	IN VIVO ANTI-INFLAMMATORY ACTIVITY OF SAPONINS FROM BUPLEURUM ROTUNDIFOLIUM.
Authors	NAVARRO,P: GINER,RM: RECIO,MC: MANEZ,S: CERDA NIVOLAS,M: RIOS,JL:
Year	2001
Volume	68
Issue	10

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Bupleurum rotundifolium (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	ECHINOCYSTIC ACID,3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]-28-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	None
2	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ECHINOCYSTIC ACID,3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]-28-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	WEAK ACTIVITY
3	Not specified	ISOLATION AND IDENTIFICATION OF	PRIMULAGENIN A,3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-FUCOPYRANOSYL]-11-METHOXY:	None
4	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PRIMULAGENIN A,3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-FUCOPYRANOSYL]-11-METHOXY:	WEAK ACTIVITY
5	Not specified	ISOLATION AND IDENTIFICATION OF	ROTUNDIOSIDE E	None
6	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTUNDIOSIDE E	WEAK ACTIVITY
7	MYELOPEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTUNDIOSIDE E	ACTIVE
8	Not specified	ISOLATION AND IDENTIFICATION OF	ROTUNDIOSIDE F	None
9	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTUNDIOSIDE F	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OF	PRIMULAGENIN A,28-O-[BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]-ESTER: 3-BETA-SULFATE	None
11	MYELOPEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	PRIMULAGENIN A,28-O-[BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]-ESTER: 3-BETA-SULFATE	INACTIVE
12	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	PRIMULAGENIN A,28-O-[BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]-ESTER: 3-BETA-SULFATE	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OF	ROTUNDIOSIDE C	None
14	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTUNDIOSIDE C	WEAK ACTIVITY
15	MYELOPEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTUNDIOSIDE C	ACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OF	OLEAN-12-ENE,3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-FUCOPYRANOSYL]-11-METHOXY-16-BETA-21-ALPHA-28-TRIHYDROXY:	None
17	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEAN-12-ENE,3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-FUCOPYRANOSYL]-11-METHOXY-16-BETA-21-ALPHA-28-TRIHYDROXY:	ACTIVE

Show SPARQL Queries (1)